4//SEC Filing
Lippa Arnold 4
Accession 0001104659-18-043794
CIK 0001583771other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 2:16 PM ET
Size
8.1 KB
Accession
0001104659-18-043794
Insider Transaction Report
Form 4
Lippa Arnold
Director
Transactions
- Purchase
Warrants
2018-07-03$1000.00/sh+8,625$8,625,000→ 8,625 total(indirect: By Trust)Exercise: $1.55From: 2018-07-03Exp: 2023-07-03→ Common Stock (8,625 underlying) - Purchase
Series C Convertible Preferred Stock
2018-07-03$1000.00/sh+15$15,000→ 15 total(indirect: By Trust)Exercise: $1.55From: 2018-07-03→ Common Stock (9,678 underlying)
Footnotes (3)
- [F1]Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55.
- [F2]Shares of Series C Convertible Preferred Stock do not expire.
- [F3]Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants
Documents
Issuer
ContraVir Pharmaceuticals, Inc.
CIK 0001583771
Entity typeother
Related Parties
1- filerCIK 0001363763
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 2:16 PM ET
- Size
- 8.1 KB